Aktuellt
SENASTE
Redeye provides a research update following Smart Eye’s Q1 2024 report. Sales fell short of its expectations, but this was offset by substantially lower costs. As a result, EBITDA came in ahead of our estimates. Further, the pipeline of potential near-term design wins appears promising. Redeye raises its EBITDA estimates for 2024e-2025e and increase its valuation range.
LÄS MER
